CLINICAL_TRIALS
trial_result
· 2025-05-09
Clinical Trial Update: SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma [Phase 2, Phase 3]
Summary
A randomized Phase 2/3 trial comparing selective internal radiation therapy (SIRT) followed by cisplatin-gemcitabine versus cisplatin-gemcitabine alone in unres…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sirtex Medical | Conditions: Intrahepatic Cholangiocarcinoma | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2025-05-09